Sanofi
730 hedge funds and large institutions have $13.2B invested in Sanofi in 2024 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 322 increasing their positions, 193 reducing their positions, and 58 closing their positions.
103% more call options, than puts
Call options by funds: $153M | Put options by funds: $75.2M
71% more capital inflows, than outflows
Capital inflows: $1.72B | Capital outflows: $1.01B
67% more repeat investments, than reductions
Existing positions increased: 322 | Existing positions reduced: 193
67% more funds holding in top 10
Funds holding in top 10: 6 → 10 (+4)
50% more first-time investments, than exits
New positions opened: 87 | Existing positions closed: 58
2% more funds holding
Funds holding: 713 → 730 (+17)
0.55% more ownership
Funds ownership: 10.32% → 10.87% (+0.55%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$259M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$231M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$173M |
| 4 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
+$153M |
| 5 |
Magnetar Financial
Evanston,
Illinois
|
+$111M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
-$486M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$89.5M |
| 3 |
Pictet Asset Management
Carouge,
Switzerland
|
-$53.3M |
| 4 |
Dodge & Cox
San Francisco,
California
|
-$49M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$39.5M |
SNY Hedge Fund Activity: Q2 2024 in Review
730 of the 6,940 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q2 2024, worth a combined $13.2B — up 5.5% from $12.6B a quarter earlier.
Buyers outnumbered sellers: 87 funds opened new SNY positions and 58 closed out — a net gain of 29 holders — while 322 added to existing stakes and 193 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $259M. The largest seller was Boston Partners, cutting an estimated $486M.
- 730 institutional investors held Sanofi (SNY) as of Q2 2024, up from 713 in Q1 2024.
- Funds reported $13.2B of Sanofi stock for Q2 2024, up 5.5% quarter-over-quarter.
- 87 funds opened new Sanofi positions in Q2 2024 and 58 closed out, a net change of +29 holders.
- The largest Sanofi buyer in Q2 2024 was Morgan Stanley, an estimated $259M added.
- The largest Sanofi seller in Q2 2024 was Boston Partners, an estimated $486M sold.
Based on aggregated 13F filings for Q2 2024.